Celldex Therapeutics, Inc. Other Noncash Income Tax Expense
Celldex Therapeutics, Inc. (CLDX) reported Other Noncash Income Tax Expense of -$529.00 thousand for the 12-month period ending 2009-12-31, per its 10-K filed 2012-03-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeTaxExpense · last filed 2012-03-08
- Celldex Therapeutics, Inc. other noncash income tax expense for fiscal 2009 was -$529.00K.
| Period end | Other Noncash Income Tax Expense 12 month |
|---|---|
| 2009-12-31 | -$529.00K 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |